Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (411-420 of 425) with videos related to

Pageof 43
Sort By:
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten cardiovascular disease risk factorsHarold E Bays, Pam R Taub, Elizabeth Epstein, et al.
Archives of Medical Science : AMS|May 20, 2022
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studiesJacek J Jóźwiak, Sławomir Kasperczyk, Tomasz Tomasik, et al.
Frontiers in Endocrinology|June 2, 2023
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implementLaszlo Rosta, Adrienn Menyhart, Wael Al Mahmeed, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 29, 2022
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthElena Lo Presti, Domenico Nuzzo, Wael Al Mahmeed, et al.
Nutrition Reviews|September 24, 2017
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelArrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Metabolites|January 21, 2023
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical EvidenceGiuseppe Mainas, Luigi Nibali, Mark Ide, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 24, 2023
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert PanelDjordje S Popovic, Nikolaos Papanas, Theocharis Koufakis, et al.
Archives of Medical Science : AMS|September 9, 2017
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelArrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 14, 2023
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Pageof 43

Showing results (411-420 of 425) with videos related to

Sort By:
Pageof 43
American Journal of Preventive Cardiology|July 30, 2021
Ten things to know about ten cardiovascular disease risk factorsHarold E Bays, Pam R Taub, Elizabeth Epstein, et al.
Archives of Medical Science : AMS|May 20, 2022
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studiesJacek J Jóźwiak, Sławomir Kasperczyk, Tomasz Tomasik, et al.
Frontiers in Endocrinology|June 2, 2023
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implementLaszlo Rosta, Adrienn Menyhart, Wael Al Mahmeed, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 29, 2022
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthElena Lo Presti, Domenico Nuzzo, Wael Al Mahmeed, et al.
Nutrition Reviews|September 24, 2017
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelArrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Metabolites|January 21, 2023
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical EvidenceGiuseppe Mainas, Luigi Nibali, Mark Ide, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 24, 2023
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert PanelDjordje S Popovic, Nikolaos Papanas, Theocharis Koufakis, et al.
Archives of Medical Science : AMS|September 9, 2017
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert PanelArrigo F G Cicero, Alessandro Colletti, Gani Bajraktari, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 14, 2023
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Pageof 43